Insider Ledger
Sealsq Corp. (LAES) insider buying and SEC filings
Sealsq Corp. · CIK 1951222
Tracked: Forms 3/4/5, 8-K, NT · Limited coverage: files 6-K/20-F, not covered in v1 · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Semiconductors & Related Devices
- State of incorporation
- D8
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$1.2M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Nov 3, 2026 | Planned (10b5-1) | Jean-Pierre Enguent (Vice President, R&DSS) sold 35,000 shares at about $1.38 ($48K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Nov 3, 2026, 5:30 PM ET |
| Oct 6, 2026 | Planned (10b5-1) | Jean-Pierre Enguent (Vice President, R&DSS) sold 35,000 shares at about $2.46 ($86K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Oct 7, 2026, 4:15 PM ET |
| Sep 3, 2026 | Planned (10b5-1) | Jean-Pierre Enguent (Vice President, R&DSS) sold 15,000 shares at about $2.40 ($36K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Sep 3, 2026 |
| Aug 5, 2026 | Planned (10b5-1) | Jean-Pierre Enguent (Vice President, R&DSS) sold 15,000 shares at about $2.46 ($37K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Aug 5, 2026 |
| Jul 8, 2026 | Planned (10b5-1) | Jean-Pierre Enguent (Vice President, R&DSS) sold 15,000 shares at about $2.82 ($42K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jul 8, 2026 |
| Jun 5, 2026 | Planned (10b5-1) | John Charles O'Hara (CFO and Director) sold 143 shares at about $3.51 ($502), marked as a 10b5-1 plan trade. Holdings down <1% to 250,431 shares. | SEC filing Filed Jun 5, 2026 |
| Jun 5, 2026 | Planned (10b5-1) | Carlos Moreira (CEO and Director) sold 300 shares at $3.51 ($1K), marked as a 10b5-1 plan trade. Holdings down <1% to 696,215 shares. | SEC filing Filed Jun 5, 2026 |
| Jun 2–3, 2026 | Planned (10b5-1) | John Charles O'Hara (CFO and Director) sold 15,582 shares between Jun 2 and Jun 3 at about $3.63 ($57K), marked as a 10b5-1 plan trade. Holdings down 6% to 250,574 shares. | SEC filing Filed Jun 3, 2026 |
| Jun 2–3, 2026 | Planned (10b5-1) | Carlos Moreira (CEO and Director) sold 17,005 shares between Jun 2 and Jun 3 at about $3.62 ($62K), marked as a 10b5-1 plan trade. Holdings down 2% to 696,515 shares. | SEC filing Filed Jun 3, 2026 |
| Jun 3, 2026 | Planned (10b5-1) | Jean-Pierre Enguent (Vice President, R&DSS) sold 15,000 shares at about $3.51 ($53K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jun 3, 2026 |
| May 27–29, 2026 | Planned (10b5-1) | John Charles O'Hara (CFO and Director) sold 14,689 shares between May 27 and May 29 at about $3.51 ($52K), marked as a 10b5-1 plan trade. Holdings down 5% to 266,156 shares. | SEC filing Filed May 29, 2026 |
| May 27–29, 2026 | Planned (10b5-1) | Carlos Moreira (CEO and Director) sold 14,139 shares between May 27 and May 29 at about $3.51 ($50K), marked as a 10b5-1 plan trade. Holdings down 2% to 713,520 shares. | SEC filing Filed May 29, 2026 |
| May 14, 2026 | Planned (10b5-1) | Franck Jean Buonanno (Vice-President, Global Sales) sold 20,000 shares at $2.90 ($58K), marked as a 10b5-1 plan trade. Holdings down 67% to 10,000 shares. | SEC filing Filed May 15, 2026 |
| May 6, 2026 | Planned (10b5-1) | Jean-Pierre Enguent (Vice President, R&DSS) sold 15,000 shares at about $3.13 ($47K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed May 7, 2026 |
| Apr 22–24, 2026 | Planned (10b5-1) | John Charles O'Hara (CFO and Director) sold 25,250 shares between Apr 22 and Apr 24 at about $2.96 ($75K), marked as a 10b5-1 plan trade. Holdings down 8% to 280,845 shares. | SEC filing Filed Apr 24, 2026 |
| Apr 20–21, 2026 | Planned (10b5-1) | John Charles O'Hara (CFO and Director) sold 20,000 shares between Apr 20 and Apr 21 at about $2.92 ($58K), marked as a 10b5-1 plan trade. Holdings down 6% to 306,095 shares. | SEC filing Filed Apr 22, 2026 |
| Apr 16–17, 2026 | Planned (10b5-1) | John Charles O'Hara (CFO and Director) sold 20,000 shares between Apr 16 and Apr 17 at about $2.71 ($54K), marked as a 10b5-1 plan trade. Holdings down 6% to 326,095 shares. | SEC filing Filed Apr 17, 2026 |
| Apr 7–9, 2026 | Planned (10b5-1) | John Charles O'Hara (CFO and Director) sold 30,000 shares between Apr 7 and Apr 9 at about $2.14 ($64K), marked as a 10b5-1 plan trade. Holdings down 12% to 215,595 shares. | SEC filing Filed Apr 9, 2026 |
| Apr 8, 2026 | Planned (10b5-1) | Jean-Pierre Enguent (Vice President, R&DSS) sold 15,000 shares at about $2.20 ($33K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Apr 9, 2026 |
| Apr 7, 2026 | Planned (10b5-1) | Moreira Andreas Feuardent (Chief Innovation Officer) sold 10,000 shares indirectly (by spouse) at $2.31 ($23K), marked as a 10b5-1 plan trade. Holdings by spouse down 100% to 0 shares. | SEC filing Filed Apr 8, 2026 |
| Apr 2–6, 2026 | Planned (10b5-1) | John Charles O'Hara (CFO and Director) sold 20,000 shares between Apr 2 and Apr 6 at about $2.44 ($49K), marked as a 10b5-1 plan trade. Holdings down 8% to 245,595 shares. | SEC filing Filed Apr 6, 2026 |
| Mar 31, 2026 | Planned (10b5-1) | Franck Jean Buonanno (Vice-President, Global Sales) sold 10,000 shares at $2.35 ($24K), marked as a 10b5-1 plan trade. Holdings down 50% to 10,000 shares. | SEC filing Filed Apr 1, 2026 |
| Mar 23–25, 2026 | Planned (10b5-1) | John Charles O'Hara (CFO and Director) sold 30,000 shares between Mar 23 and Mar 25 at about $2.94 ($88K), marked as a 10b5-1 plan trade. Holdings down 15% to 165,183 shares. | SEC filing Filed Mar 25, 2026 |
| Mar 19–20, 2026 | Planned (10b5-1) | John Charles O'Hara (CFO and Director) sold 20,000 shares between Mar 19 and Mar 20 at about $3.01 ($60K), marked as a 10b5-1 plan trade. Holdings down 9% to 195,183 shares. | SEC filing Filed Mar 23, 2026 |
| Mar 18, 2026 | Planned (10b5-1) | Nathalie Claude Odile Verjus (Company Secretary) sold 5,000 shares at about $3.03 ($15K), marked as a 10b5-1 plan trade. Holdings down 3% to 185,000 shares. | SEC filing Filed Mar 19, 2026 |
17 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow LAES in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.